{"id":2046,"date":"2003-02-01T12:07:00","date_gmt":"2003-02-01T11:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/leserbrief-bewertung-der-prosper-studie"},"modified":"2022-03-17T14:10:19","modified_gmt":"2022-03-17T13:10:19","slug":"leserbrief-bewertung-der-prosper-studie","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/leserbrief-bewertung-der-prosper-studie","title":{"rendered":"Leserbrief: Bewertung der PROSPER-Studie"},"content":{"rendered":"<p>Dr. L.B. aus M\u00fchlheim schreibt zu unserer Kleinen Mitteilung \u00fcber die PROSPER-Studie (1): >> Dieser Artikel haut einen um. Ihr schon prima vista exotisches Fazit lautet: \u201dDie PROSPER-Studie best\u00e4tigt den protektiven Effekt von Statinen &#8230; auch bei alten Menschen mit hohem kardiovaskul\u00e4rem Risiko.\u201d Damit behaupten Sie im Ernst, die alte Generation sollte mit Statinen behandelt [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. L.B. aus M\u00fchlheim schreibt zu unserer Kleinen Mitteilung \u00fcber die PROSPER-Studie (1): >> Dieser Artikel haut einen um. Ihr schon prima vista exotisches Fazit lautet: \u201dDie PROSPER-Studie best\u00e4tigt den protektiven Effekt von Statinen &#8230; auch bei alten Menschen mit hohem kardiovaskul\u00e4rem Risiko.\u201d Damit behaupten Sie im Ernst, die alte Generation sollte mit Statinen behandelt [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[800,1135,60,451,449,71,68,455,1677,2315,453,498,456,2314,65,2523,801,3126,56,443,4235],"class_list":["post-2046","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-allhat-llt-studie","tag-allhat-studie","tag-apoplektischer-insult","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-herzinfarkt","tag-hirninfarkt","tag-hmg-coa-reduktase-hemmer","tag-hope-studie","tag-hps-studie","tag-hypercholesterinaemie","tag-koronare-herzkrankheit","tag-lipidsenker","tag-mrc-bhf-hps-studie","tag-myokardinfarkt","tag-number-needed-to-treat","tag-pravastatin","tag-prosper-studie","tag-schlaganfall","tag-statine","tag-stop-hypertension-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2046"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2046\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}